The assessment of the metabolic dysfunction in patients (pts) after COVID-19 pneumonia Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021
Pulmonary function in patients recovering from severe acute respiratory syndrome (SARS) Source: Eur Respir J 2004; 24: Suppl. 48, 239s Year: 2004
Chronic obstructive pulmonary disease (COPD) and myocardial ischemia (MI) comorbidity Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB) Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006
Left ventricular dysfunction as a precipitating factor of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 513s Year: 2004
The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2011 - COPD management Year: 2011
Walking strategy in severe chronic lung disease (CLD) patients Source: Eur Respir J 2005; 26: Suppl. 49, 309s Year: 2005
Respiratory acute failure in unknown severe arterovenous malformations (MAV) in both lungs in patient with Williams syndrome (WS) Source: Annual Congress 2011 - A little bit of everything: interventional pneumology Year: 2011
Increased prevalence of obstructive airways disease (OAD) in patients with ischemic heart disease (IHD) and hypertension (HT) Source: Eur Respir J 2007; 30: Suppl. 51, 122s Year: 2007
Evaluation of Behcet‘s disease patients who admitted with pulmonary symptoms (analysis of 14 cases) Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007
Early diagnosis of late onset Pompe disease (LOPD) in patients with respiratory failure (PneumoLoped study preliminary data) Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Right heart dysfunction (RHD) in patients with acute pulmonary embolism (PE): correlation between distribution of clots, troponin I and prognosis Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
Algorithm of respiratory support (RS) in the acute respiratory failure (ARF) Source: Eur Respir J 2003; 22: Suppl. 45, 444s Year: 2003
The syndrome of respiratory failure in acute stroke patients. Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1 Year: 2020
Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes? Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Metabolic syndrome (MS) in COPD patients entering pulmonary rehabilitation (PR) Source: Annual Congress 2008 - Assessing profiles of rehabilitation candidates Year: 2008
Acute phase proteins (APP) and serum iron in patients (pts) with simple community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 805s Year: 2006